Table 6.
First Author | Years | Country | Study-Design | Sample Size | Main Finding | Rate # |
---|---|---|---|---|---|---|
Ama Sadaka [245] | 2019 | United States | Retrospective study | 35 TED patients | 20% and 31% prevalence of vitamin D deficiency and insufficiency were found in TED, respectively. | 4a |
Curtis J Heisel [246] | 2020 | United States | Retrospective case-control study | 89 TED patients (TED), 89 GD patients without TED (GD), and 2 healthy control groups matched 4:1 to the cases; 356 healthy control patients matched to the TED group (HC TED), and 356 HC patients matched to the GD (HC GD) | Low serum vitamin D is associated with TED diagnosis. Assessing and supplementing vitamin D levels may be an important addition to the early management of GD patients. | 4a |
Tereza Planck [247] | 2018 | Sweden | Cross sectional study | Epidemiological part—292 GD patients and 2305 healthy controls Clinical part—219 GD patients Relapse analysis after antithyroid drug treatment part —100 GD patients Genetic part—708 GD patients with (n = 245) or without (n = 459) ophthalmopathy and 1178 sex-matched controls |
Patients with GD had lower vitamin D levels compared to the general population; however, the vitamin D levels did not affect the laboratory or clinical parameters of GD. SNPs in the VDR influenced the risk of GD through mechanisms other than reducing the vitamin D levels. | 4a |
Thyroid eye disease (TED), Graves’ disease (GD); # LEGEND for case-control, cohort, and cross-sectional studies, rating of the studies follow the guidelines from LEGEND.